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INTRODUCTION:  
Bone loss associated with trauma osteo-
degenerative diseases and tumors has tremendous 
socioeconomic impact related to personal and 
occupation disability and health care costs. Bone 
grafting is often critical to surgical therapies. 
Autogenous bone is presently the preferred 
grafting material; however, this holds several 
disadvantages such as donor site morbidity. In the 
present climate of increasing life expectancy with 
an ensuing increase in bone-related injuries, 
orthopaedic surgery is undergoing a paradigm shift 
from bone-grafting to bone engineering, where a 
scaffold is implanted to provide adequate load 
bearing and enhance tissue regeneration.  
Our group at Queensland University of 
Technology (QUT) have developed, characterised 
and tested polycaprolactone/ tricalcium phosphate 
(PCL/TCP) composite scaffolds for low load-
bearing bone defects. These scaffolds are being 
further developed for application in higher load 
bearing sites. Our approach emphasizes the 
importance of the biomaterials’ structural design, 
the scaffold architecture and structural and 
nutritional requirements for cell culture. These 
first-generation scaffolds made from medical grade 
PCL (mPCL) have been studied for more than 5 
years within a clinical setting 1. This paper 
describes the application of second-generation 
scaffolds in small and large animal bone defect 
models and the ensuing bone regeneration as 
shown by histology and µCT. 
METHODS:  
mPCL/TCP scaffolds (80/20 wt%) were fabricated 
using fused deposition modelling. Scaffolds were 
cut to size using either biopsy punches for rat 
cranial defect studies or were custom made to 
1x1.5x2cm implants for pig cranial implantations. 
All defects sites were pre-established to be “critical 
sized” and empty defects were used as a control. 
Pig experiments are detailed schematically in Fig 
1(A, B). Cells were dispersed within fibrin glue 
and injected during implantation into selected 
scaffold/defect sites to compare  bone regenerative 
capabilities of cell versus cell-free scaffolds. 
 
Figure 1: BMSC extraction (A) and scaffold 
implantation into critical sized defect (B). After 2 
years implantation, the scaffolds plus surrounding 
host bone were explanted (C) and analysed using 
µuCT (D) and histology (E-J). 
RESULTS: 
Histological assessment using von kossa staining 
for mineralised bone (black areas E,G,H) showed 
extensive bone regeneration throughout the entire 
scaffold, supported by µCT analysis (D). Goldners 
trichrome staining showed clear osteocytes 
embedded within mineralised matrix and active 
osteoblasts present around scaffold struts (F,H,J). 
Cell groups performed better than cell-free 
scaffolds. 
DICUSSION & CONCLUSIONS:  
Bone regeneration within defects which cannot 
heal unassisted can be achieved using PCL/TCP 
scaffolds, and this is improved by the inclusion of 
autogenous BMSCs. Further work will include the 
inclusion of growth factors including BMP-2, 
VEGF and PDGF. Using knowledge of drug 
delivery and biomaterial science, multifunctional 
scaffolds, where the three-dimensional (3D) 
template itself acts as a biomimetic, programmable 
and multi-drug delivery device can be designed to 
emulate the structure and function of the 
anatomical site which provides the ultimate tool in 
successful bone tissue engineering. 
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